Amedeo Smart

Free Medical Literature Service

 

Amedeo

Valvular Heart Disease
  Free Subscription

Articles published in
Int J Cardiol
    June 2026
  1. SPANJERSBERG TCF, Hassanzada F, Jongbloed JDH, Dooijes D, et al
    Population and family data support TNNT2 p.Arg288Cys as an intermediate effect variant in hypertrophic cardiomyopathy.
    Int J Cardiol. 2026;452:134264.
    >> Share

    April 2026
  2. KAI T, Ajiro D, Yoshida T, Sekiguchi M, et al
    Comparative assessment of 4D CT-derived geometric and effective orifice areas in severe aortic stenosis.
    Int J Cardiol. 2026 Apr 2:134469. doi: 10.1016/j.ijcard.2026.134469.
    >> Share

  3. ZOCCHI C, Milazzo A, Panichella G, Garofalo M, et al
    Non-invasive evaluation of left ventricular hemodynamic force abnormalities in hypertrophic cardiomyopathy: Implications for myosin inhibition.
    Int J Cardiol. 2026;448:134175.
    >> Share

  4. BONACCHI G, Del Franco A, Agostoni P, Agricola E, et al
    Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access program.
    Int J Cardiol. 2026;448:134152.
    >> Share

  5. LUPU L, Rogers T, Abusnina W, Haberman D, et al
    Coronary access after TAVR with the 4th and 5th -generation self-expanding Evolut valves: The EPROMPT-CA study.
    Int J Cardiol. 2026;448:134073.
    >> Share

    March 2026
  6. HSIAO CS, Hsiao SH, Shiau JW, Chiou KR, et al
    Prognostic impact of systolic pulmonary and aortic regurgitation in heart failure with preserved ejection fraction.
    Int J Cardiol. 2026;454:134436.
    >> Share

  7. EL-ANDARI R, Bozso SJ
    Sex differences after valve-in-valve transcatheter aortic valve implantation: The rule or the exception?
    Int J Cardiol. 2026 Mar 18:134433. doi: 10.1016/j.ijcard.2026.134433.
    >> Share

  8. BJERREGAARD L, Maron MS, Jensen MSK, Dybro AM, et al
    Relationship between symptom assessment and cardiopulmonary exercise testing in patients with obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2026;447:134147.
    >> Share

  9. MATTA MG, Dababneh E, Camuglia A, Niranjan S, et al
    Sex differences in patient-reported and clinical outcomes after valve-in-valve TAVI: Insights from the Australian ACOR registry.
    Int J Cardiol. 2026;453:134273.
    >> Share

    February 2026
  10. FISHMAN B, Maor E, Ashri S, Loutati R, et al
    The outcome of patients with severe tricuspid regurgitation by body mass index.
    Int J Cardiol. 2026;451:134251.
    >> Share

  11. FRUMKIN D, Nersesian G, Spethmann S, Hindricks G, et al
    Acute type A aortic dissection following TAVI.
    Int J Cardiol. 2026;445:134035.
    >> Share

  12. SISINNI A, Barreiro-Perez M, Freixa X, Arzamendi D, et al
    TRI.Fr eligibility criteria and outcome in real-world cohort of patients undergoing tricuspid transcatheter edge-to-edge repair.
    Int J Cardiol. 2026;445:134021.
    >> Share

  13. JIANG J, Sun L, Hong Q, Zhang J, et al
    Comprehensive assesment of right ventricular function in patients with primary mitral regurgitation.
    Int J Cardiol. 2026 Feb 10:134232. doi: 10.1016/j.ijcard.2026.134232.
    >> Share

  14. FREIXA-BENAVENTE A, Garrido-Oliver J, Roses-Noguer F, Dux-Santoy L, et al
    Blood speckle imaging for the assessment of aortic valve velocity in healthy children: Reproducibility and comparison with Doppler echocardiography.
    Int J Cardiol. 2026 Feb 4:134223. doi: 10.1016/j.ijcard.2026.134223.
    >> Share

  15. SHEASHAA H, Farina JM, Scalia IG, Awad K, et al
    Diagnostic performance of aortic valve calcium scoring for severe aortic stenosis in patients with chronic kidney disease.
    Int J Cardiol. 2026 Feb 3:134217. doi: 10.1016/j.ijcard.2026.134217.
    >> Share

  16. POLIZZI R, Canciello G, Ordine L, di Napoli S, et al
    Reverse septal curvature in hypertrophic cardiomyopathy: Implications for function, structure and arrhythmic risk.
    Int J Cardiol. 2026;444:134013.
    >> Share

  17. BONANNI F, Ballerini A, Gozzini A, Marchi A, et al
    Autosomal recessive hypertrophic cardiomyopathy associated with variants in TRIM63.
    Int J Cardiol. 2026;444:134010.
    >> Share

  18. SAKUL S, DiazSaravia S, Berman B, Dominguez AC, et al
    "Echo-derived estimate of peak left atrial pressure in patients with iatrogenic atrial septal defects following transcatheter mitral edge-to-edge repair".
    Int J Cardiol. 2026;444:133975.
    >> Share

    January 2026
  19. CANTONE A, Serenelli M, Porcari A
    Beyond the valve: The long shadow of transthyretin amyloidosis in aortic stenosis.
    Int J Cardiol. 2026;449:134196.
    >> Share

  20. KHAN S, Balasubramanian A, Lim B, Demir O, et al
    PREDICT - patient referral evaluation to determine indication for computed tomography to identify small aortic annulus size in patients with severe aortic stenosis.
    Int J Cardiol. 2026 Jan 12:134177. doi: 10.1016/j.ijcard.2026.134177.
    >> Share

  21. PATEL KP, Autherith M, Scully PR, Koschutnik M, et al
    Long-term outcomes in patients with aortic stenosis and transthyretin cardiac amyloidosis.
    Int J Cardiol. 2026 Jan 8:134135. doi: 10.1016/j.ijcard.2025.134135.
    >> Share

  22. GAROFALO M, Scheggi V, Bohbot Y, Hasan J, et al
    Lower interventricular septal thickness from computed tomography predicts the need for pacemaker implantation after TAVR.
    Int J Cardiol. 2026;442:133915.
    >> Share

  23. TALMOR-BARKAN Y, Levi A, Barbanti M, Valvo R, et al
    The impact of contractile reserve on clinical outcomes in patients with left ventricular dysfunction undergoing TAVI.
    Int J Cardiol. 2026;442:133916.
    >> Share

  24. VESELKA J, Liebregts M, Cooper R, Faber L, et al
    Impact of centre experience on complete clinical and haemodynamic response after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Int J Cardiol. 2026;442:133865.
    >> Share

  25. NAGY V, Racz G, Takacs H, Boda K, et al
    Mavacamten effectively reduces > 100 mmHg left ventricular outflow tract gradients as early as one week of treatment in obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2026;442:133882.
    >> Share

    December 2025
  26. KHEIFETS M, Levi A, Dvir GM, Belkin D, et al
    Transcatheter aortic valve replacement in patients with cancer: A 10-year registry analysis of early and long-term mortality outcomes.
    Int J Cardiol. 2025 Dec 31:134137. doi: 10.1016/j.ijcard.2025.134137.
    >> Share

  27. GOLDENBERG GR, Barsheshet A, Erez A, Tal S, et al
    Predictors and outcomes of high ventricular pacing burden post transcatheter aortic valve replacement: 5 years of follow-up.
    Int J Cardiol. 2025;447:134138.
    >> Share

  28. GRANOT YN, Bienstock SW, Karlsberg D, Tang GHL, et al
    Correcting CT-derived aortic valve area for LVOT ellipticity: A novel approach.
    Int J Cardiol. 2025 Dec 28:134122. doi: 10.1016/j.ijcard.2025.134122.
    >> Share

  29. OBI O, Ayesha A, Lajczak P, Hageen AW, et al
    Sutureless versus transcatheter aortic valve replacement in patients with aortic stenosis: An updated meta-analysis of short- and mid-term outcomes with trial sequential analysis.
    Int J Cardiol. 2025;447:134116.
    >> Share

  30. CORCIONE N, Giordano S, Ferraro P, Morello A, et al
    Percutaneous axillary vs femoral access for transcatheter aortic valve replacement: Insights from a 2164-patient study.
    Int J Cardiol. 2025;446:134093.
    >> Share

  31. HOROWITZ H, Amsalem I, Carasso S, Postell YY, et al
    Atrial fibrillation and clinical outcomes after mitral transcatheter edge-to-edge repair: A mechanism-stratified cohort study.
    Int J Cardiol. 2025;446:134095.
    >> Share

  32. HUA L, Pang S, Zhang Z, Chen J, et al
    Long-term outcomes of tricuspid valve plasty vs. replacement after cardiac surgery: Mortality, reoperation, and anticoagulation complications in patients with postoperative tricuspid regurgitation.
    Int J Cardiol. 2025;445:134080.
    >> Share

  33. ZUIN M, Balla C, Canovi L, Serenelli M, et al
    Tricuspid annular plane systolic excursion to systolic pulmonary artery pressure ratio in Hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;440:133680.
    >> Share

  34. ATIF MM, Lohano G, Ram M, Irshad NUN, et al
    Letter to the editor: Outcomes in patients undergoing trans-catheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
    Int J Cardiol. 2025;440:133699.
    >> Share

  35. PANG X, Zhao S, Zhang F
    Comment on: "Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population".
    Int J Cardiol. 2025;440:133698.
    >> Share

    November 2025
  36. AMIR R, Ladouceur M, Danford D, Aboulhosn J, et al
    Tricuspid valve surgery in transposition of the great arteries with a systemic right ventricle.
    Int J Cardiol. 2025 Nov 25:134055. doi: 10.1016/j.ijcard.2025.134055.
    >> Share

  37. CARRION-SANCHEZ I, Monteagudo-Ruiz JM, Ramos-Cano P, Martinez-Vives P, et al
    Prognostic significance of cardiovascular magnetic resonance advanced atrial parameters in chronic significant aortic regurgitation.
    Int J Cardiol. 2025;445:134028.
    >> Share

  38. SHATANOF R, Ghay S, Fernandez R, Elajami TK, et al
    Cardiac morphologic and functional characteristics in patients with left ventricular excessive Trabeculation versus apical hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;439:133650.
    >> Share

  39. MONASTYRSKI AV, Garcia VS, Carbajal RP, Munoz JM, et al
    Single perclose escalation technique: A novel approach for vascular closure following Transcatheter Aortic Valve Replacement.
    Int J Cardiol. 2025 Nov 11:134012. doi: 10.1016/j.ijcard.2025.134012.
    >> Share

  40. PAPAZOGLOU AS, Tsiartas E, Kyriakoulis KG, Moysidis DV, et al
    Prevalence and clinical impact of baseline atherosclerotic vascular disease in patients undergoing transcatheter aortic valve implantation: A meta-analysis.
    Int J Cardiol. 2025;444:134004.
    >> Share

    October 2025
  41. XIE P, Zhou H, Huang Y, Huang Z, et al
    Left ventricular diastolic function modifies clinical outcomes of mild mitral regurgitation.
    Int J Cardiol. 2025 Oct 31:133998. doi: 10.1016/j.ijcard.2025.133998.
    >> Share

  42. GONZALEZ-GOMEZ A, Monteagudo Ruiz JM, Arteagoitia Bolumburu A, Mahia P, et al
    The 4A classification for prognostic stratification of patients with tricuspid regurgitation. A multicenter study.
    Int J Cardiol. 2025;444:133977.
    >> Share

  43. SCHOONVELDE SAC, Nollet EE, Zwetsloot PP, Knackstedt C, et al
    Genotype-negative hypertrophic cardiomyopathy: Exploring the role of cardiovascular risk factors in disease expression.
    Int J Cardiol. 2025;437:133444.
    >> Share

  44. BATOOL SJ, Hasan M
    Comment on "Assessing the accuracy of echocardiographic estimation of pulmonary pressures: Insights from a 5-grade tricuspid regurgitation classification".
    Int J Cardiol. 2025 Oct 7:133966. doi: 10.1016/j.ijcard.2025.133966.
    >> Share

  45. YANG L, Chen X, Fang Y, Chen D, et al
    Rate-adaptive pacing in right-sided heart failure with tricuspid regurgitation: A prospective pilot study.
    Int J Cardiol. 2025 Oct 6:133957. doi: 10.1016/j.ijcard.2025.133957.
    >> Share

  46. AVIEL G, Hirsh-Raccah B, Idais I, Ghannam RA, et al
    Worsening tricuspid regurgitation after mitral valve surgery: a meta-analysis and meta-regression.
    Int J Cardiol. 2025 Oct 4:133931. doi: 10.1016/j.ijcard.2025.133931.
    >> Share

  47. ZENG XM, Su Q, Mo LR
    Serum Alpha-1-microglobulin (A1M) and calcific aortic valve stenosis.
    Int J Cardiol. 2025 Oct 2:133953. doi: 10.1016/j.ijcard.2025.133953.
    >> Share

  48. BURTON SM, Nelson M, Rigo G, Caputo M, et al
    Risk factors and clinical impact of transvalvular gradient following surgical repair of degenerative mitral regurgitation.
    Int J Cardiol. 2025 Oct 1:133929. doi: 10.1016/j.ijcard.2025.133929.
    >> Share

    September 2025
  49. HA ET, Phichaphop A, Case BC
    Concomitant coronary artery disease in those undergoing TAVR for severe aortic stenosis: A benign finding?
    Int J Cardiol. 2025 Sep 30:133948. doi: 10.1016/j.ijcard.2025.133948.
    >> Share

  50. ALPERI A, Avanzas P
    SAPIEN 3 in type 0 bicuspid aortic valves: Promising early results.
    Int J Cardiol. 2025;443:133918.
    >> Share

  51. KIRK BH, Palm P, Norgaard MW, Borregaard B, et al
    Prevention of readmission by intensified follow-up after transcatheter aortic valve implantation: Feasibility results of the PREMISS randomised controlled trial.
    Int J Cardiol. 2025 Sep 14:133894. doi: 10.1016/j.ijcard.2025.133894.
    >> Share

  52. ZAHID MH, Saleem M, Murtaza A
    Letter to the editor: Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study.
    Int J Cardiol. 2025 Sep 6:133859. doi: 10.1016/j.ijcard.2025.133859.
    >> Share

  53. LUNZE FI, Dusenbery SM, Gauvreau K, Lee JM, et al
    Mid-term ventricular function in patients with tetralogy of Fallot after transcatheter pulmonary valve replacement: Relationship to baseline right ventricular loading conditions.
    Int J Cardiol. 2025;434:133305.
    >> Share

    August 2025
  54. SHAWKI M, Sampaio Rodrigues T, Khabazi KP, Brick C, et al
    Short-term incidence and risk of atrial fibrillation in patients with hypertrophic cardiomyopathy receiving cardiac myosin inhibitors: A systematic review and meta-analysis.
    Int J Cardiol. 2025;442:133846.
    >> Share

  55. DUAN YN
    Letter to the editor: Trends in mitral valve surgery for mitral valve regurgitation in Denmark: Changes in patient characteristics and mortality from 1996 to 2022.
    Int J Cardiol. 2025 Aug 26:133829. doi: 10.1016/j.ijcard.2025.133829.
    >> Share

  56. SCHOPS LB, Fosbol EL, Ostergaard L
    Response to Letter to the Editor: Trends in mitral valve surgery for mitral valve regurgitation in Denmark: Reinterpreting patient characteristics and institutional effects.
    Int J Cardiol. 2025 Aug 26:133830. doi: 10.1016/j.ijcard.2025.133830.
    >> Share

  57. MARGONATO D, Morosato M, Ingallina G, Wang C, et al
    Natural history outcome of moderate tricuspid regurgitation with preserved left-ventricular ejection fraction.
    Int J Cardiol. 2025;442:133826.
    >> Share

  58. DONAL E, Rasmeehirun P, Petersen Saadi M
    From bottle to decanter: Revisiting eRVSP accuracy in the five-grade tricuspid regurgitation era.
    Int J Cardiol. 2025 Aug 20:133805. doi: 10.1016/j.ijcard.2025.133805.
    >> Share

  59. MELILLO F, Speziale G
    Mitral valve treatment for mitral valve regurgitation: The past, the present and the future - A challenge for the surgeon and the imager.
    Int J Cardiol. 2025 Aug 19:133784. doi: 10.1016/j.ijcard.2025.133784.
    >> Share

  60. SCHOPS LB, Fosbol EL, Ostergaard L
    Response to letter to editor: Concerns on methodology and interpretation in Schops' study on mitral valve surgery trends.
    Int J Cardiol. 2025 Aug 19:133808. doi: 10.1016/j.ijcard.2025.133808.
    >> Share

  61. GITTO M, Kim WK, Buono A, Fabris T, et al
    Clinical outcomes in women and men with raphe-type bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
    Int J Cardiol. 2025;441:133792.
    >> Share

  62. FENG D, Wang M, Wang J, Liu X, et al
    Safety and efficacy of transcatheter aortic valve replacement using Sapien 3 balloon-expandable valve in type 0 bicuspid aortic valve stenosis patients.
    Int J Cardiol. 2025;441:133791.
    >> Share

  63. LATERRA G, Barbanti M, Rosato S, Biancari F, et al
    Incidence of cardiac ischemic events after transcatheter aortic valve replacement: Results from the OBSERVANT studies.
    Int J Cardiol. 2025 Aug 12:133779. doi: 10.1016/j.ijcard.2025.133779.
    >> Share

  64. ANNALISA P, Andrea P, Monica F, Giuseppe C, et al
    Genereux staging classification in predicting left ventricular reverse remodeling after intervention for severe aortic valve regurgitation.
    Int J Cardiol. 2025 Aug 12:133770. doi: 10.1016/j.ijcard.2025.133770.
    >> Share

  65. TARTAGLIA F, Gitto M, Villaschi A, Calamita G, et al
    Transcatheter therapies for tricuspid regurgitation: A meta-analysis of randomized trials.
    Int J Cardiol. 2025 Aug 11:133777. doi: 10.1016/j.ijcard.2025.133777.
    >> Share

  66. YANG T, Wang Y, Zhu G, Liu W, et al
    TRI-PLAN: A deep learning-based automated assessment framework for right heart assessment in transcatheter tricuspid valve replacement planning.
    Int J Cardiol. 2025 Aug 6:133732. doi: 10.1016/j.ijcard.2025.133732.
    >> Share

  67. YU C
    Letter to the editor: Concerns on methodology and interpretation in Schops' study on mitral valve surgery trends.
    Int J Cardiol. 2025 Aug 6:133723. doi: 10.1016/j.ijcard.2025.133723.
    >> Share

  68. MEI Z, Guo C, Yang H, Li J, et al
    Serum Alpha-1-microglobulin (A1M) as an independent predictor of calcific aortic valve stenosis and its diagnostic value.
    Int J Cardiol. 2025;440:133706.
    >> Share

  69. ARSHAD A, Melin M, Lund LH, Manouras A, et al
    Assessing the accuracy of echocardiographic estimation of pulmonary pressures: Insights from a 5-grade tricuspid regurgitation classification.
    Int J Cardiol. 2025;440:133729.
    >> Share

  70. WANG B
    Letter to the Editor: Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
    Int J Cardiol. 2025 Aug 4:133701. doi: 10.1016/j.ijcard.2025.133701.
    >> Share

  71. SHI W, Wang M, Niu G, Zhao Z, et al
    Management of TAVR in asymptomatic or minimally symptomatic patients: Insights from resting angiographic microvascular resistance.
    Int J Cardiol. 2025;432:133263.
    >> Share

  72. AAMIR M, Bilquees A, Saleem D
    Addressing confounding factors in TEER outcomes: A call for deeper analysis [Re: Meulengracht et al., International Journal of Cardiology 439 (2025) 133605 - "Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared t
    Int J Cardiol. 2025 Aug 1:133702. doi: 10.1016/j.ijcard.2025.133702.
    >> Share

    July 2025
  73. GHAFFAR MD, Khan MA
    Refining patient selection and outcome assessment in transcatheter edge-to-edge mitral valve repair: Reflections on a Nationwide Danish study.
    Int J Cardiol. 2025;440:133679.
    >> Share

  74. PAGNESI M, Adamo M
    Reply to letter: Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025;439:133611.
    >> Share

  75. MEULENGRACHT DE, Petersen JK, Veien KT, de Backer O, et al
    Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
    Int J Cardiol. 2025 Jul 7:133605. doi: 10.1016/j.ijcard.2025.133605.
    >> Share

  76. ROGERS LJ, Dong T, Kota R, Chan J, et al
    Reoperative mitral valve surgery in the UK: 20-year trends and early outcomes.
    Int J Cardiol. 2025 Jul 5:133602. doi: 10.1016/j.ijcard.2025.133602.
    >> Share

  77. XU Z, Chen L, Dai X, Lin Z, et al
    Midterm outcomes of thoracoscopic trans-mitral myectomy for hypertrophic obstructive cardiomyopathy: A single-center, observational study.
    Int J Cardiol. 2025;430:133216.
    >> Share

    June 2025
  78. CELEGHIN R, Pilichou K
    Mitral valve prolapse: A clinical puzzle in search of molecular solutions.
    Int J Cardiol. 2025 Jun 30:133563. doi: 10.1016/j.ijcard.2025.133563.
    >> Share

  79. REN CB, van den Dorpel MMP, Geleijnse M, van Mieghem NM, et al
    How accurate is intraprocedural transthoracic echocardiography in assessing aortic regurgitation after transcathether aortic valve implantation? A single center experience.
    Int J Cardiol. 2025;438:133565.
    >> Share

  80. SONG Y, Ma F, Bao X, Liu Y, et al
    Letter to editor: Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025 Jun 25:133560. doi: 10.1016/j.ijcard.2025.133560.
    >> Share

  81. BARILI F, Pollari F, Marin-Cuartas M, Anselmi A, et al
    Time-to-event analysis of the long-term outcome in trials comparing transcatheter and surgical aortic valve implantation: A meta-analysis.
    Int J Cardiol. 2025 Jun 24:133524. doi: 10.1016/j.ijcard.2025.133524.
    >> Share

  82. SCHOPS LB, Truong S, Petersen J, Alhakak A, et al
    Trends in mitral valve surgery for mitral valve regurgitation in Denmark: Changes in patient characteristics and mortality from 1996 to 2022.
    Int J Cardiol. 2025;438:133552.
    >> Share

  83. SCHREURS BA, van Kimmenade RRJ, Eijsvogels TMH
    Reply by Schreurs et al. to letter regarding article: Physical activity characteristics in adults with bicuspid aortic valve versus age and sex matched controls.
    Int J Cardiol. 2025 Jun 20:133545. doi: 10.1016/j.ijcard.2025.133545.
    >> Share

  84. IMRAN A, Haider A
    Comment on "Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study".
    Int J Cardiol. 2025;438:133534.
    >> Share

  85. AWAD DM
    Bridging the Gap: Addressing the Underuse of Transcatheter Edge-to-Edge Repair in Chinese Patients with Significant Mitral Regurgitation.
    Int J Cardiol. 2025;438:133519.
    >> Share

  86. VESELKA J, Hansvenclova E, Tesarkova KH, Januska J, et al
    Comparable outcomes in single versus multiple septal branches alcohol ablation for obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;429:133145.
    >> Share

  87. LORENZATTI A
    Cholesterol and Valvular heart disease: Is Lipoprotein(a) the sole culprit?
    Int J Cardiol. 2025;437:133510.
    >> Share

  88. TREMAMUNNO G, De Santis D, Santangeli C, Bona GG, et al
    Comparative analysis of pre-transcatheter aortic valve implantation CTA protocols: Optimizing radiation dose and contrast volume.
    Int J Cardiol. 2025;437:133514.
    >> Share

  89. JARRAR Y, Alomari L, Otabor E, Lam J, et al
    A safer bet for MitraClip: Choosing between single antiplatelet therapy and dual antiplatelet therapy.
    Int J Cardiol. 2025;437:133476.
    >> Share

    May 2025
  90. LORETZ L, Kim WK, de Backer O, Brunner S, et al
    PVL in ACURATE neo2 self-expanding aortic valve prosthesis for transcatheter aortic valve replacement - A multicenter retrospective registry analysis.
    Int J Cardiol. 2025;436:133428.
    >> Share

  91. TRUONG S, Fosbol E, Ostergaard L
    Reply to "Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A critical perspective".
    Int J Cardiol. 2025 May 27:133431. doi: 10.1016/j.ijcard.2025.133431.
    >> Share

  92. NONAKA H, Asami M, Horiuchi Y, Tanaka J, et al
    Validation of MitraScore in diverse mitral regurgitation subtypes: Insights from the OCEAN-mitral registry.
    Int J Cardiol. 2025 May 27:133427. doi: 10.1016/j.ijcard.2025.133427.
    >> Share

  93. EBRAHIMI S
    Early aortic valve replacement in asymptomatic severe aortic stenosis: A turning point in management.
    Int J Cardiol. 2025;435:133411.
    >> Share

  94. BLACKMAN DJ, Aktaa S, Pickles D, Abdel-Wahab M, et al
    REdo transcatheter aortic VALVE implantation for the management of transcatheter aortic valve failure: Design and rationale of the REVALVE study.
    Int J Cardiol. 2025 May 18:133400. doi: 10.1016/j.ijcard.2025.133400.
    >> Share

  95. HASSAN SAU, Huda NU, Maheen M
    Letter to the editor: Physical activity characteristics in adults with bicuspid aortic valve versus age and sex matched controls.
    Int J Cardiol. 2025;435:133392.
    >> Share

  96. JABRI A, Suri RM, Villablanca P
    Redo or Redon't? Mitral valve reoperation vs. first-time surgery outcomes: A nationwide study.
    Int J Cardiol. 2025;434:133353.
    >> Share

  97. FATH AR, Aglan A, Maron MS, Phillips JS, et al
    Cardiovascular outcomes of glucagon-like peptide-1 agonist in patients with obesity and hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;426:133082.
    >> Share

    April 2025
  98. CHEN B, Wang C, Li W
    Comprehensive genetic analysis based on multi - omics reveals novel therapeutic targets for mitral valve prolapse and drug molecular dynamics simulation.
    Int J Cardiol. 2025 Apr 29:133325. doi: 10.1016/j.ijcard.2025.133325.
    >> Share

  99. SCHREURS BA, van der Sluijs KM, Hopman MTE, Bakker EA, et al
    Physical activity characteristics in adults with bicuspid aortic valve versus age- and sex-matched controls.
    Int J Cardiol. 2025 Apr 29:133330. doi: 10.1016/j.ijcard.2025.133330.
    >> Share

  100. ROQUEMEN-ECHEVERRI V, Jacobs PG, Shalen EF, Schulman PM, et al
    Reply to: Correction to external evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as reference standard.
    Int J Cardiol. 2025;433:133310.
    >> Share

  101. WEI P, Zhao G, Dong J, Feng S, et al
    Anatomical suitability and clinical outcomes of transcatheter edge-to-edge repair in Chinese patients with significant mitral regurgitation: A real-world echocardiographic study.
    Int J Cardiol. 2025;433:133317.
    >> Share

  102. MAYNTZ SP, Davidovski FS
    Improving gender-specific management of aortic stenosis with IMPULSE registry data.
    Int J Cardiol. 2025;433:133293.
    >> Share

  103. SITGES M
    Improving our management of tricuspid regurgitation: present and future opportunities.
    Int J Cardiol. 2025 Apr 18:133288. doi: 10.1016/j.ijcard.2025.133288.
    >> Share

  104. MCDONOUGH RV
    Correction to: External evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as reference standard (Int J Cardiol. 2025;419:132653).
    Int J Cardiol. 2025;432:133260.
    >> Share

  105. JACQUEMYN X, Sa MP, Marin-Cuartas M, Bax JJ, et al
    Early aortic valve replacement versus conservative management in asymptomatic severe aortic stenosis: Meta-analysis of time-to-event data of randomized controlled trials.
    Int J Cardiol. 2025;432:133269.
    >> Share

  106. IFTIKHAR MK, Iftikhar QUA, Baig MMA
    Mitral valve reoperation: Refining risk stratification for better outcomes.
    Int J Cardiol. 2025;431:133239.
    >> Share

  107. JAVED MN, Ahmed U, Eman NU
    Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A critical perspective.
    Int J Cardiol. 2025;431:133238.
    >> Share

    March 2025
  108. BLEIZIFFER S, Messika-Zeitoun D, Steeds R, Appleby C, et al
    Gender differences in the presentation and management of patients with severe aortic stenosis at specialist versus primary/sondary care centres: A sub-analysis of the IMPULSE enhanced registry.
    Int J Cardiol. 2025 Mar 30:133223. doi: 10.1016/j.ijcard.2025.133223.
    >> Share

  109. LUO D, Bjornson E, Wang X, Zhang B, et al
    Distinct lipoprotein contributions to valvular heart disease: Insights from genetic analysis.
    Int J Cardiol. 2025 Mar 27:133218. doi: 10.1016/j.ijcard.2025.133218.
    >> Share

  110. TRUONG S, Petersen J, Havers-Borgersen E, Schops LB, et al
    Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study.
    Int J Cardiol. 2025 Mar 18:133175. doi: 10.1016/j.ijcard.2025.133175.
    >> Share

  111. CAI Y, Ou M, Li Y, Zhang X, et al
    Parameters of speckle tracking echocardiography in right atrial fibrosis of patients with rheumatic mitral stenosis: Focusing on right atrial stiffness.
    Int J Cardiol. 2025;429:133170.
    >> Share

  112. LAI Q, Wei Z, Zhang X, Li Q, et al
    The passability of delivery catheter system during self-expanding transcatheter aortic valve replacement: A CT-based prediction model.
    Int J Cardiol. 2025 Mar 16:133168. doi: 10.1016/j.ijcard.2025.133168.
    >> Share

  113. GODINO C, Nemola G, Sisinni A, Margonato D, et al
    Therapeutical approach of tricuspid regurgitation and right heart failure.
    Int J Cardiol. 2025;429:133163.
    >> Share

  114. SONAGLIONI A, Nicolosi GL, Lombardo M
    Navigating the prognostic risk stratification of moderate and severe asymptomatic aortic stenosis.
    Int J Cardiol. 2025;429:133141.
    >> Share

  115. AHMED A, Safiriyu I, Kaddoura R, Mohyeldin M, et al
    Outcomes of transcatheter aortic valve implantation in Africa: A systematic review and meta-analysis.
    Int J Cardiol. 2025 Mar 10:133139. doi: 10.1016/j.ijcard.2025.133139.
    >> Share

  116. PANCALDI E, Adamo M, Pagnesi M, Russo G, et al
    Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025 Mar 9:133137. doi: 10.1016/j.ijcard.2025.133137.
    >> Share

  117. TAKAHARI K, Utsunomiya H, Tohgi K, Hamada A, et al
    Tissue-tracking mitral annular displacement predicts impaired left ventricular mechanics and adverse outcomes in aortic stenosis with preserved left ventricular ejection fraction.
    Int J Cardiol. 2025 Mar 2:133106. doi: 10.1016/j.ijcard.2025.133106.
    >> Share

  118. FERRI LA, Ancona MB, Papageorgiou C, Vella C, et al
    Computed tomography derived predictors of left ventricular obstruction after TAVR.
    Int J Cardiol. 2025;422:132956.
    >> Share

  119. KHAN S, Demir O, Mehmood M, Nabi I, et al
    An automated method of streamlining waiting list by clinical risk fast-tracking for patients awaiting TAVR: SWIFT TAVR algorithm.
    Int J Cardiol. 2025;422:132952.
    >> Share

  120. SCHOONVELDE SAC, Alexandridis GM, Price LB, Schinkel AFL, et al
    Family screening for hypertrophic cardiomyopathy: Initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals.
    Int J Cardiol. 2025;422:132951.
    >> Share

    February 2025
  121. AKITA K, Suwa K, Ohno K, Weiner SD, et al
    Detection of late gadolinium enhancement in patients with hypertrophic cardiomyopathy using machine learning.
    Int J Cardiol. 2025;421:132911.
    >> Share

  122. GULER A, Erata YE, Demirtola AI, Turkmen I, et al
    The effect of disopyramide therapy on functional capacity improvement in patients with obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;421:132913.
    >> Share

  123. ZENG X, Wu H, Wang R, Huang P, et al
    Major adverse cardiovascular events after modified morrow surgery in hypertrophic obstructive cardiomyopathy: A 12-year cohort study.
    Int J Cardiol. 2025;421:132864.
    >> Share

  124. ABBAS MT, Farina JM, Awad K, Badr A, et al
    The association of bisphosphonates, calcium levels and PTH levels with bioprosthetic aortic valve degeneration.
    Int J Cardiol. 2025;425:133067.
    >> Share

  125. KOLIASTASIS L, Kim WK
    Coronary physiology assessment in severe aortic stenosis: Feasible yet challenging.
    Int J Cardiol. 2025 Feb 13:133063. doi: 10.1016/j.ijcard.2025.133063.
    >> Share

    January 2025
  126. ALNABTI A, Abujalala S, Al-Hijji M, Othman K, et al
    Outcomes of the Transcatheter aortic valve implantation- registry (QATAVI-registry) -first report 24/7/2024.
    Int J Cardiol. 2025 Jan 29:133029. doi: 10.1016/j.ijcard.2025.133029.
    >> Share

  127. TUSA M, Amicone S
    Rediscovering racial disparities in tricuspid regurgitation: A call for increased and targeted treatment approach.
    Int J Cardiol. 2025 Jan 25:133007. doi: 10.1016/j.ijcard.2025.133007.
    >> Share

  128. LU T, Zhu C, Cui H, Meng Y, et al
    Preoperative D-dimer and outcomes in obstructive hypertrophic cardiomyopathy after myectomy.
    Int J Cardiol. 2025;419:132705.
    >> Share

  129. JENSEN RV, Jensen JM, Iraqi N, Grove EL, et al
    Coronary CT angiography instead of invasive angiography before TAVI: Feasibility and outcomes.
    Int J Cardiol. 2025;419:132694.
    >> Share

  130. ZHANG L, Ding F, Ren Z, Cheng W, et al
    Mechanisms of pathogenicity in the hypertrophic cardiomyopathy-associated TNNI3 c.235C > T variant.
    Int J Cardiol. 2025;419:132627.
    >> Share

  131. KIM M, Seo J, Kim IS, Cho S, et al
    Differential determinants and prognostic value of aortic valve sclerosis over carotid atherosclerosis.
    Int J Cardiol. 2025 Jan 11:132980. doi: 10.1016/j.ijcard.2025.132980.
    >> Share

  132. KAGAMI K, Kagiyama N, Kaneko T, Harada T, et al
    Heart failure with preserved ejection fraction in atrial functional mitral regurgitation - Insight from the REVEAL-AFMR.
    Int J Cardiol. 2025;422:132958.
    >> Share

    December 2024
  133. GAMARRA-VALVERDE NN, Masket D, Henry ML, Mares AC, et al
    Anticoagulation therapy for the prevention of subclinical leaflet thrombosis after transcatheter aortic valve replacement: A comprehensive literature review and future directions.
    Int J Cardiol. 2024 Dec 28:132946. doi: 10.1016/j.ijcard.2024.132946.
    >> Share

  134. ALBULUSHI A, Al-Abri U, Al Matrooshi N, Alsabti H, et al
    Pulmonary hypertension as a prognostic marker in low-flow low-gradient aortic stenosis: Insights from invasive hemodynamics and post-TAVR outcomes.
    Int J Cardiol. 2024;421:132910.
    >> Share

  135. MUSHTAQ S, Chiesa M, Novelli V, Sommariva E, et al
    Role of advanced CMR features in identifying a positive genotype of hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;417:132554.
    >> Share

  136. HAGEGE A, Puscas T, El Hachmi M, Parodi A, et al
    The French hypertrophic cardiomyopathy gene register: A systematic large gene screening for hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;417:132542.
    >> Share

  137. CORCIONE N, Ferraro P, Finizio F, Cimmino M, et al
    Overall impact of tethering and of its symmetric and asymmetric subtypes on early and long-term outcome of transcatheter edge-to-edge repair of significant mitral valve regurgitation.
    Int J Cardiol. 2024;421:132874.
    >> Share

  138. CESMAT AP, Chaudry AM, Gupta S, Weickert TT, et al
    Left ventricular hypertrophy and ventricular ectopy in mitral valve prolapse.
    Int J Cardiol. 2024;421:132888.
    >> Share

  139. ECHARTE-MORALES J, Scotti A, Bonnet G, Torrado J, et al
    Racial and ethnic disparities in patients with severe tricuspid regurgitation: The Bronx-Valve registry.
    Int J Cardiol. 2024;421:132889.
    >> Share

  140. SAIJO Y, Okushi Y, Gillinov AM, Pettersson GB, et al
    Sex-related differences in outcomes and prognosis of severe calcific mitral stenosis due to mitral annular calcification: A propensity-score matched cohort study.
    Int J Cardiol. 2024;421:132893.
    >> Share

  141. KIM WK, Bleiziffer S
    Are there sex-specific disparities in transcatheter aortic valve implantation?
    Int J Cardiol. 2024;421:132882.
    >> Share

  142. PANG S, Wu J, Ke Y, Wang Q, et al
    Letter to the Editor: Insight into functional tricuspid valve regurgitation pathogenesis, pathological stages, and surgical management.
    Int J Cardiol. 2024;421:132883.
    >> Share

  143. YAN T, Weng F, Guo C
    miR-124-3p may exert its effects in hypertrophic cardiomyopathy by inhibiting cardiomyocyte apoptosis.
    Int J Cardiol. 2024;416:132470.
    >> Share

    November 2024
  144. FEZZI S, Pesarini G, Flaim M, Ding D, et al
    Influence of physiological patterns of coronary disease on fractional flow reserve and instantaneous wave-free ratio changes in patients undergoing TAVI.
    Int J Cardiol. 2024 Nov 25:132761. doi: 10.1016/j.ijcard.2024.132761.
    >> Share

  145. HAFIANE A, Pisaturo A, Favari E, Bortnick AE, et al
    Atherosclerosis, calcific aortic valve disease and mitral annular calcification: Same or different?
    Int J Cardiol. 2024 Nov 16:132741. doi: 10.1016/j.ijcard.2024.132741.
    >> Share

  146. BERGHMANS S, Eyskens B, Rega F, Moons P, et al
    A retrospective study: Long term prognosis in adults with PA-VSD-MAPCAs.
    Int J Cardiol. 2024;415:132476.
    >> Share

  147. SANNA GD, Finocchiaro G
    Sarcomere gene mutations in hypertrophic cardiomyopathy: how to clinically manage this information?
    Int J Cardiol. 2024;415:132373.
    >> Share

  148. BONAVENTURA J, Maron BJ
    Chasing the molecular background of hypertrophic cardiomyopathy: The continuing saga to predict adverse outcomes with sarcomere mutations.
    Int J Cardiol. 2024;415:132366.
    >> Share

  149. PEREIRA AR, Al Jaff AAM, Cabezas JM, de Weger A, et al
    Unilateral-access vs. bilateral-access in transfemoral transcatheter aortic valve replacement: A slim fit approach.
    Int J Cardiol. 2024 Nov 14:132712. doi: 10.1016/j.ijcard.2024.132712.
    >> Share

  150. ABRAHAM B, Sous M, Kaldas S, Nakhla M, et al
    Transcaval access for transcatheter aortic valve implantation: A meta-analysis and systematic review.
    Int J Cardiol. 2024 Nov 11:132720. doi: 10.1016/j.ijcard.2024.132720.
    >> Share

  151. LIN S, Zhang Y, Wang S, Ding X, et al
    Prognostic utility of dynamic changes in epicardial adipose tissue in patients undergoing transcatheter aortic valve replacement.
    Int J Cardiol. 2024 Nov 10:132697. doi: 10.1016/j.ijcard.2024.132697.
    >> Share

  152. EL MATHARI S, Hopman LHGA, Bouchnaf C, Heidendael JF, et al
    Clinical implications of different methods to assess left atrial remodeling: A comparative study between echocardiography and cardiac magnetic resonance imaging for left atrial volume index quantification.
    Int J Cardiol. 2024;414:132443.
    >> Share

  153. FERNANDEZ A, Niel N, Parma G, Loza G, et al
    Warfarin use is associated with higher aortic bioprosthetic 18F-fluoride PET uptake.
    Int J Cardiol. 2024;414:132394.
    >> Share

    October 2024
  154. YANG Y, Ye Y
    Women: More susceptible to develop unfavorable in-hospital outcomes after transcatheter aortic valve replacement.
    Int J Cardiol. 2024 Oct 22:132678. doi: 10.1016/j.ijcard.2024.132678.
    >> Share

  155. ALPERI A, Avanzas P
    TAVR in tapered raphe-type stenotic bicuspid aortic valves: excellent results in challenging anatomies.
    Int J Cardiol. 2024 Oct 19:132656. doi: 10.1016/j.ijcard.2024.132656.
    >> Share

  156. ROQUEMEN-ECHEVERRI V, Jacobs PG, Shalen EF, Schulman PM, et al
    External evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as reference standard.
    Int J Cardiol. 2024 Oct 19:132653. doi: 10.1016/j.ijcard.2024.132653.
    >> Share

  157. FIGLIOZZI S, Masci PG, Monti L, Stankowski K, et al
    Prognostic value of right ventricular involvement in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Int J Cardiol. 2024;413:132390.
    >> Share

  158. KUMAR M, Hu JR, Ali S, Khlidj Y, et al
    Sex disparities in outcomes of transcatheter aortic valve implantation- a multi-year propensity-matched nationwide study.
    Int J Cardiol. 2024;418:132619.
    >> Share

  159. TRUONG S, Petersen J, Schmiegelow MDS, Due H, et al
    Incidence and factors associated with mitral valve reoperation in patients undergoing surgery for mitral regurgitation: A nationwide cohort study.
    Int J Cardiol. 2024;418:132608.
    >> Share

    September 2024
  160. SAITO T, Tsuruta H, Iwata J, Kajino A, et al
    Impact of beta-blocker uptitration on patients after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation: The OCEAN-mitral registry.
    Int J Cardiol. 2024 Sep 24:132595. doi: 10.1016/j.ijcard.2024.132595.
    >> Share

  161. BUONO A, De Biase C, Fabris T, Bellamoli M, et al
    CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry.
    Int J Cardiol. 2024 Sep 18:132569. doi: 10.1016/j.ijcard.2024.132569.
    >> Share

  162. HARIKRISHNAN S, Koshy L, Ganapathi S, Jeemon P, et al
    Clinical exome sequencing unravels the diverse spectrum of genetic heterogeneity and genotype-phenotype correlations in hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;411:132273.
    >> Share

  163. BANSAL S, Gupta A
    TAVR outcomes in females - What is changing!
    Int J Cardiol. 2024;411:132247.
    >> Share

  164. ABU-MUCH A, Grines CL, Chen S, Batchelor WB, et al
    Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI.
    Int J Cardiol. 2024;417:132555.
    >> Share

  165. PISKLOVA M, Osmak G
    Unveiling MiRNA-124 as a biomarker in hypertrophic cardiomyopathy: An innovative approach using machine learning and intelligent data analysis.
    Int J Cardiol. 2024;410:132220.
    >> Share

  166. GOMEZ-HERRERO J, Fernandez-Cordon C, Gonzalez JC, Garcia-Gomez M, et al
    TAV-in-TAV in patients with prosthesis embolization: Impact of commissural alignment and global outcomes.
    Int J Cardiol. 2024;410:132179.
    >> Share

    August 2024
  167. MARGONATO D
    The therapeutical role of balloon aortic valvuloplasty: Back to the origin?
    Int J Cardiol. 2024 Aug 28:132493. doi: 10.1016/j.ijcard.2024.132493.
    >> Share

  168. BONFIOLI GB, Pagnesi M
    Pulmonary vein flow pattern: A marker of successful repair in primary mitral regurgitation?
    Int J Cardiol. 2024 Aug 28:132498. doi: 10.1016/j.ijcard.2024.132498.
    >> Share

  169. LAI KY, Lee CY, Chang YC, Liu K, et al
    Prognostic value of fully-automated left atrial strain in patients with asymptomatic chronic severe aortic regurgitation.
    Int J Cardiol. 2024 Aug 27:132487. doi: 10.1016/j.ijcard.2024.132487.
    >> Share

  170. LIU T, Yang X, Jia R, Han J, et al
    Left atrial mechanical dispersion and left atrial stiffness predicts recurrence of atrial fibrillation: In patients with moderate-severe rheumatic mitral stenosis.
    Int J Cardiol. 2024 Aug 26:132480. doi: 10.1016/j.ijcard.2024.132480.
    >> Share

  171. HUANG Z, Lin K, Huang J, Chen Y, et al
    Characteristics and outcomes associated with sarcomere mutations in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Int J Cardiol. 2024;409:132213.
    >> Share

  172. FAN J, Li Z, Lin D, Miao J, et al
    Long-term outcomes in patients with bicuspid valve stenosis and aortic dilation undergoing transcatheter valve implantation.
    Int J Cardiol. 2024;409:132201.
    >> Share

  173. FAGGI A, Denti P
    Contemporary TAVI counterindications and space for staged procedures.
    Int J Cardiol. 2024;409:132172.
    >> Share

  174. NASIR MM, Amir S, Shahid A, Rehman WU, et al
    Valve-in-valve transcatheter mitral valve replacement versus redo-surgical mitral valve replacement for degenerated bioprosthetic mitral valves: A systematic review and meta-analysis.
    Int J Cardiol. 2024;415:132448.
    >> Share

  175. AMSALEM I, Carasso S
    Increased utilization of mitral transcatheter edge-to-edge repair in degenerative mitral regurgitation: The essential need for better prognostic and procedural success tools.
    Int J Cardiol. 2024 Aug 14:132457. doi: 10.1016/j.ijcard.2024.132457.
    >> Share

  176. GE Z, Ge Z, Hu C, Wang Y, et al
    Characteristic of myocardial work in mitral valve prolapse with versus without mitral annular disjunction: A propensity-matched study.
    Int J Cardiol. 2024 Aug 6:132434. doi: 10.1016/j.ijcard.2024.132434.
    >> Share

  177. YEDIDYA I, Stassen J, Butcher S, van Wijngaarden AL, et al
    The prognostic value of changes in pulmonary vein flow patterns after surgical repair for primary mitral regurgitation.
    Int J Cardiol. 2024;414:132414.
    >> Share

  178. YAGI N, Hasegawa H, Kuwajima K, Ogawa M, et al
    Indexed aortic valve area using multimodality imaging for assessing the severity of bicuspid aortic stenosis.
    Int J Cardiol. 2024;414:132416.
    >> Share

  179. SPRINGHETTI P, Tomaselli M, Clavel MA
    Measuring the aortic valvular area: Key challenges in aortic stenosis assessment.
    Int J Cardiol. 2024;414:132410.
    >> Share

  180. LORCA R, Salgado M, Alvarez-Velasco R, Reguro JR, et al
    Survival analysis and gender differences in hypertrophic cardiomyopathy proband patients referred for genetic testing.
    Int J Cardiol. 2024;408:132117.
    >> Share

  181. TONDI L, Pica S, Crimi G, Disabato G, et al
    "Interstitial fibrosis is associated with left atrial remodeling and adverse clinical outcomes in selected low-risk patients with hypertrophic cardiomyopathy".
    Int J Cardiol. 2024;408:132135.
    >> Share

  182. BESOLA L, Falcetta G, Ceravolo G, Fiocco A, et al
    New echocardiographic screening tool for left ventricular tract obstruction risk assessment in TMVR.
    Int J Cardiol. 2024;408:132112.
    >> Share

    July 2024
  183. HUSSAIN B, Tarabanis C, Aslam MMS, Dhulipala V, et al
    Inpatient outcomes of mechanical circulatory support devices and heart transplantation in hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;413:132396.
    >> Share

  184. RAHOUMA M, Khairallah S, Lau C, Al Zghari T, et al
    The impact of comorbidities on outcomes of concomitant mitral valve intervention with ascending aortic surgery.
    Int J Cardiol. 2024;413:132398.
    >> Share

  185. KELLY B, Thorup L, Telinius N, Mohanakumar S, et al
    Lymphatic morphology and function in chronic right heart failure due to secondary tricuspid valve regurgitation.
    Int J Cardiol. 2024;413:132399.
    >> Share

  186. TOMSIC A, Holubec T, Sandoval E, Pham T, et al
    Mitral valve repair with resection and non-resection techniques in Barlow's disease: A multi-center study.
    Int J Cardiol. 2024 Jul 22:132387. doi: 10.1016/j.ijcard.2024.132387.
    >> Share

  187. DE FELICE F, Musto C, Paolucci L
    TAVR in bicuspid aortic valve and ascending aorta dilatation: sitting on a fence or jumping on the bandwagon.
    Int J Cardiol. 2024 Jul 19:132372. doi: 10.1016/j.ijcard.2024.132372.
    >> Share

  188. AMADOR AF
    Edmonton frail scale in TAVI patients: A new tool for frailty assessment and outcomes prediction.
    Int J Cardiol. 2024;407:132024.
    >> Share

  189. DAYAN V, Fernandez A, Loza G, Parma G, et al
    Early anticoagulation after aortic valve replacement with porcine bioprosthesis randomized control trial(ANTIPRO). 3?years follow-up.
    Int J Cardiol. 2024 Jul 12:132361. doi: 10.1016/j.ijcard.2024.132361.
    >> Share

  190. ALBANI S, Merlo M
    Left ventricle late gadolinium enhancement and risk of atrial fibrillation in patients with hypertrophic cardiomyopathy: Another brick towards a precise approach.
    Int J Cardiol. 2024;413:132357.
    >> Share

  191. LOFFI M, Adamo M, Rubbio AP, Pezzola E, et al
    Prevalence and outcome of elderly and low-risk patients with degenerative mitral regurgitation undergoing transcatheter edge-to-edge repair.
    Int J Cardiol. 2024 Jul 8:132317. doi: 10.1016/j.ijcard.2024.132317.
    >> Share

  192. FUJIMOTO T, Zen K, Kataoka E, Kitada T, et al
    Balloon aortic valvuloplasty bridge to transcatheter aortic valve replacement is associated with worse in-hospital mortality.
    Int J Cardiol. 2024 Jul 6:132348. doi: 10.1016/j.ijcard.2024.132348.
    >> Share

  193. OMAR P, Giovanni B, Williams J, Thomas F, et al
    Quantification of anatomical aortic valve area by multi-detector computed tomography: A pilot 3D-morphological modeling of the stenotic aortic valve.
    Int J Cardiol. 2024 Jul 6:132322. doi: 10.1016/j.ijcard.2024.132322.
    >> Share

  194. HEEGER CH, Alagjozovski H
    Editorial to: Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial.
    Int J Cardiol. 2024;412:132299.
    >> Share

  195. BONANNI M, Russo G, De Siati M, Tomao F, et al
    Holographic mixed reality for planning transcatheter aortic valve replacement.
    Int J Cardiol. 2024 Jul 2:132330. doi: 10.1016/j.ijcard.2024.132330.
    >> Share

  196. TIRADO-CONTE G, Pardo Sanz A, Salido Tahoces L
    Ascending aortic dilatation in TAVI: Actor or bystander?
    Int J Cardiol. 2024;406:132089.
    >> Share

    June 2024
  197. RUSSO G, Hahn RT, Alessandrini H, Andreas M, et al
    Effects of tricuspid transcatheter edge-to-edge repair on tricuspid annulus diameter - Data from the TriValve registry.
    Int J Cardiol. 2024;405:131934.
    >> Share

  198. LV J, Wu Y, Xu H
    Transcatheter mitral valve intervention in patients with cancer: More efforts are needed.
    Int J Cardiol. 2024 Jun 15:132271. doi: 10.1016/j.ijcard.2024.132271.
    >> Share

  199. HOLLOWELL M, Banno J, Marsy D, Shrestha N, et al
    Ventricular late gadolinium enhancement by cardiac MRI as a predictor of atrial fibrillation in hypertrophic cardiomyopathy.
    Int J Cardiol. 2024 Jun 13:132263. doi: 10.1016/j.ijcard.2024.132263.
    >> Share

  200. ALPERI A, Pascual I, Moris C, Avanzas P, et al
    Valve-in-valve after transcatheter aortic valve embolization: Do we need to align the commissures?
    Int J Cardiol. 2024 Jun 11:132255. doi: 10.1016/j.ijcard.2024.132255.
    >> Share

  201. D'AMARIO D, Laborante R, Mennuni M, Adamo M, et al
    Efficacy and safety of trans-catheter repair devices for mitral regurgitation: A systematic review and meta-analysis.
    Int J Cardiol. 2024 Jun 6:132245. doi: 10.1016/j.ijcard.2024.132245.
    >> Share

  202. AYYAD M, Jabri A, Khalefa BB, Al-Abdouh A, et al
    Efficacy and safety of TAVR versus SAVR in patients with small aortic annuli: A systematic review and meta-analysis.
    Int J Cardiol. 2024 Jun 6:132243. doi: 10.1016/j.ijcard.2024.132243.
    >> Share

  203. KIRCHNER J, Gercek M, Gesch J, Omran H, et al
    Artificial intelligence-analyzed computed tomography in patients undergoing transcatheter tricuspid valve repair.
    Int J Cardiol. 2024 Jun 5:132233. doi: 10.1016/j.ijcard.2024.132233.
    >> Share

  204. SUNAGA A, Matsuoka Y, Nakatani D, Okada K, et al
    Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial.
    Int J Cardiol. 2024 Jun 3:132231. doi: 10.1016/j.ijcard.2024.132231.
    >> Share

  205. PARATZ ED, Stub D, Sutherland N, Gutman S, et al
    Response to: Regard to assessing agreement between two raters with kappa statistics.
    Int J Cardiol. 2024;404:131978.
    >> Share

  206. GESKE JB, Schaff HV
    Role of experience in myectomy for hypertrophic cardiomyopathy: With very high procedural volume, myectomy remains low-risk even with concomitant procedure need.
    Int J Cardiol. 2024;404:131961.
    >> Share

  207. ANG SP, Chia JE
    Reevaluating female survival benefit in TAVR: A closer look in the current era.
    Int J Cardiol. 2024;404:131935.
    >> Share

    May 2024
  208. SHI W, Feng D, Hu X, Wang C, et al
    Prediction of hypoattenuating leaflet thickening in patients underwent transcatheter aortic valves replacement based on clinical factors and 4D-computed tomography morphological characteristics: A retrospective cross-sectional study.
    Int J Cardiol. 2024 May 28:132219. doi: 10.1016/j.ijcard.2024.132219.
    >> Share

  209. AURIGEMMA C, Busco M, Bianchini F, Bianchini E, et al
    Clinical impact of multiple resheathing during transcatheter aortic valve implantation with Evolut self-expanding valves.
    Int J Cardiol. 2024 May 28:132218. doi: 10.1016/j.ijcard.2024.132218.
    >> Share

  210. WAZZAN AAL, Taconne M, Rolle VL, Forsaa MI, et al
    Risk profiles for ventricular arrhythmias in hypertrophic cardiomyopathy through clustering analysis including left ventricular strain.
    Int J Cardiol. 2024 May 24:132167. doi: 10.1016/j.ijcard.2024.132167.
    >> Share

  211. RELLA V, Maurizi N, Bernardini A, Brasca FM, et al
    Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2024 May 23:132202. doi: 10.1016/j.ijcard.2024.132202.
    >> Share

  212. MARTIN M, Rozado J
    Imaging in severe aortic stenosis: Looking at the future.
    Int J Cardiol. 2024 May 16:132183. doi: 10.1016/j.ijcard.2024.132183.
    >> Share

  213. SEE C, Kim Y, Park J, Wang Y, et al
    High- versus low-gradient aortic stenosis: Is our evaluation limited by aorto-mitral angle on cardiovascular CT?
    Int J Cardiol. 2024 May 14:132174. doi: 10.1016/j.ijcard.2024.132174.
    >> Share

  214. MONDA E, Boccia A, Altobelli I, Mauriello A, et al
    Effect of beta-blockers and angiotensin receptor blockers in reducing the aortic growth rate in children with bicuspid aortic valve-related aortopathy.
    Int J Cardiol. 2024;408:132067.
    >> Share

  215. VOGES I, Hansen JH
    Critical aortic stenosis - The long-term burden.
    Int J Cardiol. 2024;408:132134.
    >> Share

  216. ALPERI A, Pascual I, Moris C, Avanzas P, et al
    Neo 2 transcatheter heart valve system: Direct towards a minimalistic procedure.
    Int J Cardiol. 2024;402:131883.
    >> Share

  217. VESELKA J
    Estimating the risk of sudden death in hypertrophic cardiomyopathy might be solved by artificial intelligence.
    Int J Cardiol. 2024;402:131842.
    >> Share

  218. GARAGOLI F, Chiabrando JG, Seropian IM, Lombardi M, et al
    Stroke risk after transcatheter aortic valve replacement in patients with carotid stenosis: A systematic review and meta-analysis.
    Int J Cardiol. 2024 May 1:132085. doi: 10.1016/j.ijcard.2024.132085.
    >> Share

    April 2024
  219. QIU Y, Li M, Song X, Li Z, et al
    Predictive nomogram for 28-day mortality risk in mitral valve disorder patients in the intensive care unit: A comprehensive assessment from the MIMIC-III database.
    Int J Cardiol. 2024 Apr 25:132105. doi: 10.1016/j.ijcard.2024.132105.
    >> Share

  220. LEE CY, Tsai CM, Chiang KC, Huang CC, et al
    Prognostic value of left ventricular and left atrial strain imaging in moderate to severe aortic stenosis: Insights from an Asian population.
    Int J Cardiol. 2024 Apr 25:132103. doi: 10.1016/j.ijcard.2024.132103.
    >> Share

  221. CHEN B, Zhang Q
    The role of left ventricular global work index on the prediction of cardiovascular mortality after transcatheter aortic valve implantation.
    Int J Cardiol. 2024 Apr 23:132101. doi: 10.1016/j.ijcard.2024.132101.
    >> Share

  222. MARMAGKIOLIS K, Monlezun DJ, Caballero J, Cilingiroglu M, et al
    Prevalence, mortality, cost, and disparities in transcatheter mitral valve repair and replacement in cancer patients: Artificial intelligence and propensity score national 5-year analysis of 7495 procedures.
    Int J Cardiol. 2024 Apr 23:132091. doi: 10.1016/j.ijcard.2024.132091.
    >> Share

  223. GUO Y, Li H, Huang B, Hou L, et al
    LncRNA HOTAIR ameliorates calcific aortic valve disease by sponging miR-29b.
    Int J Cardiol. 2024 Apr 23:132094. doi: 10.1016/j.ijcard.2024.132094.
    >> Share

  224. GERHARDT P, Shehu N, Ferrari I, Hullebrandt M, et al
    Quantifying aortic valve regurgitation in patients with congenital aortic valve disease by 2D and 4D flow magnetic resonance analysis.
    Int J Cardiol. 2024 Apr 21:132084. doi: 10.1016/j.ijcard.2024.132084.
    >> Share

  225. DAHME T
    Effects of tricuspid edge-to-edge repair beyond leaflet approximation: Evidence for indirect tricuspid annuloplasty.
    Int J Cardiol. 2024;406:132066.
    >> Share

  226. SADEGHIPOUR P, Mozafarybazargany M, Farrashi M, De Caterina R, et al
    Response to "Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants".
    Int J Cardiol. 2024 Apr 20:132076. doi: 10.1016/j.ijcard.2024.132076.
    >> Share

  227. PRAKASH SK
    Editorial on Bellino et al., "Aortopathy and aortic valve surgery in patients with bicuspid aortic valve with and without raphe".
    Int J Cardiol. 2024 Apr 16:132047. doi: 10.1016/j.ijcard.2024.132047.
    >> Share

  228. CHENG Y, Zhang Q
    Commentary on the mitral regurgitation outcomes after transcatheter atrial septal defect closure.
    Int J Cardiol. 2024 Apr 6:132033. doi: 10.1016/j.ijcard.2024.132033.
    >> Share

  229. ALTIBI AM, Sapru A, Ghanem F, Zhao Y, et al
    Impact of concomitant surgical interventions on outcomes of septal myectomy in obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;400:131790.
    >> Share

  230. DE SA MARCHI MF, van den Dorpel M, Calomeni P, Chatterjee S, et al
    Comparative analysis of different risk prediction tools after mitral Transcatheter edge-to-edge repair.
    Int J Cardiol. 2024;400:131768.
    >> Share

    March 2024
  231. SANG SLW, Weissman C, Parker J, Timek T, et al
    Contemporary outcomes of surgical aortic valve replacement in patients referred for a transcatheter approach.
    Int J Cardiol. 2024 Mar 30:132004. doi: 10.1016/j.ijcard.2024.132004.
    >> Share

  232. BELLINO M, Antonini-Canterin F, Bossone E, Faggiano P, et al
    Aortopathy and aortic valve surgery in patients with bicuspid aortic valve with and without raphe.
    Int J Cardiol. 2024 Mar 30:132000. doi: 10.1016/j.ijcard.2024.132000.
    >> Share

  233. BLEIZIFFER S, Appleby C, Delgado V, Eltchaninoff H, et al
    Patterns of aortic valve replacement in Europe and adoption by sex.
    Int J Cardiol. 2024 Mar 28:131996. doi: 10.1016/j.ijcard.2024.131996.
    >> Share

  234. KALKAN S, Gursoy MO, Guner A, Kalcik M, et al
    Management of prosthetic valve thrombosis with unfractionated heparin.
    Int J Cardiol. 2024 Mar 19:131968. doi: 10.1016/j.ijcard.2024.131968.
    >> Share

  235. BICHUETTE LD, Lottenberg MP, Caramelli B
    Hypertrophic cardiomyopathy as a high-risk feature on perioperative care: How to deal with this self-fulfilling prophecy?
    Int J Cardiol. 2024;399:131683.
    >> Share

  236. ZACH DK, Schwegel N, Santner V, Winkelbauer L, et al
    Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;399:131661.
    >> Share

  237. NASCIMENTO BR, Nunes MCP, da Silva JLP, Steer A, et al
    Outcomes of latent rheumatic heart disease: External validation of a simplified score in patients with and without secondary prophylaxis.
    Int J Cardiol. 2024;399:131662.
    >> Share

  238. FENG D, Zhao J, Niu G, Zhang Y, et al
    Outcomes for patients undergoing transcatheter aortic valve replacement with ascending aorta dilation.
    Int J Cardiol. 2024 Mar 11:131948. doi: 10.1016/j.ijcard.2024.131948.
    >> Share

  239. BONELLO B, Issitt R, Hughes M, Carr M, et al
    Long-term outcome after neonatal intervention for congenital critical aortic stenosis.
    Int J Cardiol. 2024 Mar 2:131932. doi: 10.1016/j.ijcard.2024.131932.
    >> Share

  240. BARSSOUM K, Abumoawad A, Chowdhury M, Agrawal A, et al
    Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database.
    Int J Cardiol. 2024;398:131601.
    >> Share

  241. LIU Z, Wei P, Jiang H, Zhang F, et al
    Corrigendum to 'Alerting trends in epidemiology for non-rheumatic degenerative mitral valve disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease Study 2019' [Int. J. Cardiol. 395(2024) 131561].
    Int J Cardiol. 2024 Mar 1:131919. doi: 10.1016/j.ijcard.2024.131919.
    >> Share

    February 2024
  242. BOURG C, Lee KC, Donal E
    Understanding myocardial mechanics in primary mitral regurgitation: A contemporary approach.
    Int J Cardiol. 2024 Feb 17:131882. doi: 10.1016/j.ijcard.2024.131882.
    >> Share

  243. DI MAURO M, Guarracini S, Mazzocchetti L, Capuzzi D, et al
    Transcatheter bicaval valve system for the treatment of severe isolated tricuspid regurgitation. Features from a single-Centre experience.
    Int J Cardiol. 2024 Feb 16:131864. doi: 10.1016/j.ijcard.2024.131864.
    >> Share

  244. AKHTAR KH, Pahuja M, Baber U
    Self-expanding or balloon-expandable valve for TAVR in low risk patients: The jury is still out!
    Int J Cardiol. 2024;397:131619.
    >> Share

  245. DE MARZO V, Zimarino M
    The value of transaxillary access for TAVI.
    Int J Cardiol. 2024;397:131448.
    >> Share

  246. FATIMA K, Uddin QS, Tharwani ZH, Kashif MAB, et al
    Concomitant transthyretin cardiac amyloidosis in patients undergoing TAVR for aortic stenosis: A systemic review and meta-analysis.
    Int J Cardiol. 2024 Feb 15:131854. doi: 10.1016/j.ijcard.2024.131854.
    >> Share

  247. DANDEL M
    It is time to think about further optimization of the echocardiographic assessment of left ventricular responses to mitral regurgitation.
    Int J Cardiol. 2024 Feb 9:131841. doi: 10.1016/j.ijcard.2024.131841.
    >> Share

  248. KWAK S, Lee HJ, Lee H, Park JB, et al
    Age-dependent association of metabolic dyslipidemia with clinical expression of hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;396:131574.
    >> Share

    January 2024
  249. KURASAWA S, Imaizumi T, Kondo T, Hishida M, et al
    Relationship between peak aortic jet velocity and progression of aortic stenosis in patients undergoing hemodialysis.
    Int J Cardiol. 2024 Jan 30:131822. doi: 10.1016/j.ijcard.2024.131822.
    >> Share

  250. ELKOUMY A, Ruck A, Abdel-Wahab M, Thiele H, et al
    ACURATE neo2 Transcatheter aortic valve implantation without balloon aortic valvuloplasty - direct ACURATE neo2.
    Int J Cardiol. 2024 Jan 19:131792. doi: 10.1016/j.ijcard.2024.131792.
    >> Share

  251. MUSUMECI B, Tini G, Biagini E, Merlo M, et al
    Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.
    Int J Cardiol. 2024 Jan 18:131784. doi: 10.1016/j.ijcard.2024.131784.
    >> Share

  252. CARABETTA N, Siller-Matula JM, Boccuto F, Panuccio G, et al
    Commissural alignment during TAVR reduces the risk of overlap to coronary ostia.
    Int J Cardiol. 2024;395:131572.
    >> Share

  253. PARATZ ED, Stub D, Sutherland N, Gutman S, et al
    The challenge of risk stratification in hypertrophic cardiomyopathy: Clinical, genetic and imaging insights from a quaternary referral centre.
    Int J Cardiol. 2024;395:131416.
    >> Share

  254. DEL FRANCO A, Biagioni G, Mazzoni C, Cappelli F, et al
    Amyloidosis in spinal stenosis: How, when and whether cardiac screening has a clinical impact.
    Int J Cardiol. 2024;395:131413.
    >> Share

  255. SRAYA R, Amsalem I, Carasso S, Gilad O, et al
    Mitral valve gradient changes associate with outcomes of patients undergoing transcatheter edge-to-edge repair.
    Int J Cardiol. 2024 Jan 9:131766. doi: 10.1016/j.ijcard.2024.131766.
    >> Share

  256. PASTORE MC, Vannuccini F, Mandoli GE, Lisi M, et al
    Myocardial work and left heart deformation parameters across primary mitral regurgitation severity.
    Int J Cardiol. 2024 Jan 9:131772. doi: 10.1016/j.ijcard.2024.131772.
    >> Share

  257. LERMAN TT, Levi A, Kornowski R
    Response to: "Evolut R and Evolut PRO vs. Sapien 3 for transcatheter aortic valve implantation - The 'generation gap' and beyond".
    Int J Cardiol. 2024 Jan 5:131751. doi: 10.1016/j.ijcard.2024.131751.
    >> Share

  258. VAN WELY M, van Nieuwkerk AC, Rooijakkers M, van der Wulp K, et al
    Transaxillary versus transfemoral access as default access in TAVI: A propensity matched analysis.
    Int J Cardiol. 2024;394:131353.
    >> Share

    December 2023
  259. MOSCARELLA E, Ielasi A, Montonati C, Pellegrini D, et al
    Comparing two-year outcomes of balloon-expandable Myval and self-expanding Evolut R in severe aortic valve stenosis.
    Int J Cardiol. 2023 Dec 31:131701. doi: 10.1016/j.ijcard.2023.131701.
    >> Share

  260. ANWER S, Nussbaum S, Winkler NE, Benz DC, et al
    Left ventricular global work index and prediction of cardiovascular mortality after transcatheter aortic valve implantation.
    Int J Cardiol. 2023 Dec 29:131660. doi: 10.1016/j.ijcard.2023.131660.
    >> Share

  261. HIRAM R
    The duration of atrial fibrillation might be associated with right heart disease severity.
    Int J Cardiol. 2023 Dec 28:131689. doi: 10.1016/j.ijcard.2023.131689.
    >> Share

  262. ANTIA A, Pius R, Ndukauba C, Zarauz VR, et al
    Temporal trends in the utilization and outcome of transcatheter aortic valve replacement across racial and ethnic groups. A nationwide analysis.
    Int J Cardiol. 2023 Dec 22:131669. doi: 10.1016/j.ijcard.2023.131669.
    >> Share

  263. CAETANO L DA SILVA, Gibicoski TB, Rodriguez F, Scabello I, et al
    Impact of carotid artery stenosis on outcomes of transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Int J Cardiol. 2023 Dec 22:131670. doi: 10.1016/j.ijcard.2023.131670.
    >> Share

  264. ADAMO M, Pagnesi M, Di Pasquale M, Ravera A, et al
    Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF.
    Int J Cardiol. 2023 Dec 21:131664. doi: 10.1016/j.ijcard.2023.131664.
    >> Share

  265. IZUMI K, Utsunomiya H, Takeuchi M, Hamada A, et al
    Relationship between duration of atrial fibrillation and right heart structure remodeling as assessed by 3-dimensional transesophageal echocardiography.
    Int J Cardiol. 2023 Dec 21:131667. doi: 10.1016/j.ijcard.2023.131667.
    >> Share

  266. BOLETI OD, Roussos S, Norrish G, Field E, et al
    Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of events.
    Int J Cardiol. 2023;393:131405.
    >> Share

  267. MORONI A, Tondi L, Milani V, Pieroni M, et al
    Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A CMR-based head-to-head comparison and outcome analysis.
    Int J Cardiol. 2023;393:131357.
    >> Share

  268. OZLEK B
    Tricuspid regurgitation and heart failure with preserved ejection fraction: An enigma in cardiology practice.
    Int J Cardiol. 2023 Dec 10:131649. doi: 10.1016/j.ijcard.2023.131649.
    >> Share

  269. GOZDEK M, Kowalewski M
    Evolut R and Evolut PRO vs. Sapien 3 for transcatheter aortic valve implantation - The 'generation gap' and beyond.
    Int J Cardiol. 2023 Dec 8:131647. doi: 10.1016/j.ijcard.2023.131647.
    >> Share

  270. SEE C, Wang Y, Yang Y, Tirziu D, et al
    Impact of sex on transcatheter aortic valve replacement outcomes: Results of a single-center study.
    Int J Cardiol. 2023 Dec 6:131643. doi: 10.1016/j.ijcard.2023.131643.
    >> Share

  271. HOLIEROOK M, Henstra MJ, Dolman DJ, Chekanova EV, et al
    Higher Edmonton Frail Scale prior to transcatheter Aortic Valve Implantation is related to longer hospital stay and mortality.
    Int J Cardiol. 2023 Dec 6:131637. doi: 10.1016/j.ijcard.2023.131637.
    >> Share

  272. MATTIG I, Steudel T, Barzen G, Frumkin D, et al
    Diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and Fabry disease.
    Int J Cardiol. 2023 Dec 3:131629. doi: 10.1016/j.ijcard.2023.131629.
    >> Share

  273. DORIAN D, Scolari FL, Habib M, Brahmbhatt DH, et al
    Association of duration and intensity of exercise with phenotypic expression in hypertrophic cardiomyopathy.
    Int J Cardiol. 2023;392:131253.
    >> Share

    November 2023
  274. FERNANDEZ-GOLFIN C, Gonznalez-Gomez A
    Unmasking tricuspid regurgitation.
    Int J Cardiol. 2023 Nov 28:131609. doi: 10.1016/j.ijcard.2023.131609.
    >> Share

  275. KIKUCHI S, Minamimoto Y, Matsushita K, Cho T, et al
    Ratio of left ventricular outflow tract area to aortic annulus area and complete atrioventricular block after transcatheter aortic valve replacement for aortic stenosis.
    Int J Cardiol. 2023 Nov 27:131608. doi: 10.1016/j.ijcard.2023.131608.
    >> Share

  276. CHAN J, Narayan P, Fudulu DP, Dong T, et al
    Trend in mitral valve prostheses of choice and early outcomes in the United Kingdom.
    Int J Cardiol. 2023 Nov 25:131607. doi: 10.1016/j.ijcard.2023.131607.
    >> Share

  277. HAUGE SW, Estensen ME, Persson R, Abebe S, et al
    The importance of concomitant mitral regurgitation for estimates of mitral valve area by pressure half time in patients with chronic rheumatic heart disease.
    Int J Cardiol. 2023 Nov 21:131600. doi: 10.1016/j.ijcard.2023.131600.
    >> Share

  278. MOSCARELLI M, Sollami G, Lentini E, Prestera R, et al
    About different localization of hypoattenuated lesions following transcatheter aortic valve replacement.
    Int J Cardiol. 2023 Nov 16:131597. doi: 10.1016/j.ijcard.2023.131597.
    >> Share

  279. HU D, Lan T, Chen Y, Chen L, et al
    An 18-year evolution of congenital heart disease in China: An echocardiographic database-based study.
    Int J Cardiol. 2023;391:131286.
    >> Share

  280. KHOURY S, Bhatia RT, Marwaha S, Miles C, et al
    Ethnic and sex-related differences at presentation in apical hypertrophic cardiomyopathy: An observational cross-sectional study.
    Int J Cardiol. 2023;391:131265.
    >> Share

  281. WU Z, Nie C, Zhu C, Meng Y, et al
    Mitral annular calcification in obstructive hypertrophic cardiomyopathy: Incidence, risk factors, and prognostic value after myectomy.
    Int J Cardiol. 2023;391:131266.
    >> Share

  282. DE SARRO R, Sabatino J
    Left atrial function's evaluation in aortic stenosis: A clinical imperative.
    Int J Cardiol. 2023 Nov 11:131579. doi: 10.1016/j.ijcard.2023.131579.
    >> Share

  283. LOSI MA, Monda E, Lombardi R, Lioncino M, et al
    Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy.
    Int J Cardiol. 2023 Nov 9:131575. doi: 10.1016/j.ijcard.2023.131575.
    >> Share

  284. ZHOU N, Liu A, Weng H, Liu W, et al
    Three-dimensional echocardiography reveals early mitral valve alterations in hypertrophic cardiomyopathy genetic mutation carriers.
    Int J Cardiol. 2023 Nov 8:131576. doi: 10.1016/j.ijcard.2023.131576.
    >> Share

  285. DORES H, Toste A, Cardim N
    Hypertrophic cardiomyopathy in patients with a normal electrocardiogram: A view from the east side of the Atlantic Ocean.
    Int J Cardiol. 2023;390:131260.
    >> Share

  286. SALA A, Alfieri O
    Surgical ablation in hypertrophic obstructive cardiomyopathy: What is the real deal?
    Int J Cardiol. 2023;390:131146.
    >> Share

  287. NEMES A
    Three-dimensional echocardiography for Tricuspid Annulus - Transthoracic or transoesophageal approach?
    Int J Cardiol. 2023;390:131170.
    >> Share

    October 2023
  288. BRANDES A
    Rheumatic mitral valve stenosis and atrial fibrillation - Vicious twins.
    Int J Cardiol. 2023 Oct 30:131566. doi: 10.1016/j.ijcard.2023.131566.
    >> Share

  289. LIU Z, Wei P, Jiang H, Zhang F, et al
    Alerting trends in epidemiology for non-rheumatic degenerative mitral valve disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease Study 2019.
    Int J Cardiol. 2023 Oct 30:131561. doi: 10.1016/j.ijcard.2023.131561.
    >> Share

  290. MOSCARELLI M, Prestera R, Fiore C, Pernice V, et al
    Evaluation of the anatomic sinus after transcatheter aortic valve replacement.
    Int J Cardiol. 2023 Oct 20:131551. doi: 10.1016/j.ijcard.2023.131551.
    >> Share

  291. HOU Q, Wu W, Fang L, Zhang X, et al
    Patient-specific computational fluid dynamics for hypertrophic obstructive cardiomyopathy.
    Int J Cardiol. 2023;389:131263.
    >> Share

  292. BADWAN O, Mirzai S, Skoza W, Hawk F, et al
    Clinical outcomes following tricuspid transcatheter edge-to-edge repair with PASCAL: A meta-analysis.
    Int J Cardiol. 2023;389:131194.
    >> Share

  293. LEONARDI D, Bursi F, Fanti D, Dotto A, et al
    Outpatient tricuspid regurgitation in the community: Clinical context and outcome.
    Int J Cardiol. 2023 Oct 14:131443. doi: 10.1016/j.ijcard.2023.131443.
    >> Share

  294. BHOGAL S, Waksman R, Shea C, Zhang C, et al
    Self-expanding and balloon-expandable valves in low risk TAVR patients.
    Int J Cardiol. 2023 Oct 12:131431. doi: 10.1016/j.ijcard.2023.131431.
    >> Share

  295. MYAGMARDORJ R, Stassen J, Nabeta T, Hirasawa K, et al
    Impact of chronic obstructive pulmonary disease on right ventricular function and remodeling after aortic valve replacement.
    Int J Cardiol. 2023 Oct 5:131414. doi: 10.1016/j.ijcard.2023.131414.
    >> Share

  296. CHEN X
    The real world of stroke incidence in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2023;388:131172.
    >> Share

  297. MARTIN M, Moris C
    Subclinical leaflet thrombosis after TAVI: To be or not to be.
    Int J Cardiol. 2023;388:131140.
    >> Share

    September 2023
  298. YAMANO M, Yamano T, Nakamura T, Zukeran T, et al
    Mitral regurgitation outcomes after transcatheter atrial septal defect closure.
    Int J Cardiol. 2023 Sep 28:131404. doi: 10.1016/j.ijcard.2023.131404.
    >> Share

  299. WINKLER NE, Anwer S, Rumpf PM, Tsiourantani G, et al
    Left atrial pump strain predicts long-term survival after transcatheter aortic valve implantation.
    Int J Cardiol. 2023 Sep 28:131403. doi: 10.1016/j.ijcard.2023.131403.
    >> Share

  300. CHANG WT, Lin CH, Lee WC, Kan WC, et al
    Signal intensity coefficient as a detector of aortic stenosis-induced myocardial fibrosis and its correlation to the long term outcome.
    Int J Cardiol. 2023 Sep 17:131367. doi: 10.1016/j.ijcard.2023.131367.
    >> Share

  301. KHARBANDA RK, Ramdat Misier NL, Van den Eynde J, El Mathari S, et al
    Outcomes of concomitant surgical ablation in patients undergoing surgical myectomy for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.
    Int J Cardiol. 2023;387:131099.
    >> Share

  302. SOARES JR, Carvalho VT, Lodi-Junqueira L, Fonseca IMG, et al
    Assessment of the left atrial volume and function following percutaneous mitral balloon valvuloplasty: Insights into acute and late impact of atrial fibrillation on atrial remodeling.
    Int J Cardiol. 2023 Sep 12:131361. doi: 10.1016/j.ijcard.2023.131361.
    >> Share

  303. LEOW R, Kong WKF, Li TY, Poh KK, et al
    Yeo's index: A novel index that combines anatomic and haemodynamic assessment of the severity of mitral stenosis.
    Int J Cardiol. 2023 Sep 7:131350. doi: 10.1016/j.ijcard.2023.131350.
    >> Share

  304. HASEGAWA H, Kuwajima K, Kagawa S, Yamane T, et al
    Impact of eccentric jet on outcomes in patients with atrial functional mitral regurgitation: An echocardiographic study.
    Int J Cardiol. 2023 Sep 5:131342. doi: 10.1016/j.ijcard.2023.131342.
    >> Share

  305. YAMAZAKI C, Higuchi R, Saji M, Takamisawa I, et al
    Discrepancy between invasive and echocardiographic transvalvular gradient after TAVI: Insights from the LAPLACE-TAVI registry.
    Int J Cardiol. 2023;386:17-23.
    >> Share

    August 2023
  306. GENTILE F, Buoncristiani F, Sciarrone P, Bazan L, et al
    Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation.
    Int J Cardiol. 2023 Aug 19:131272. doi: 10.1016/j.ijcard.2023.131272.
    >> Share

  307. LI S, Fang L, Wu W, Zhang Z, et al
    Echocardiographic diagnosis of rupture of mitral valve papillary muscle.
    Int J Cardiol. 2023 Aug 18:131273. doi: 10.1016/j.ijcard.2023.131273.
    >> Share

  308. PIERONI M, Ciabatti M, Bolognese L
    Stroke in hypertrophic cardiomyopathy. Never mind the rhythm.
    Int J Cardiol. 2023;385:41-42.
    >> Share

  309. NEMES A
    The tricuspid annulus in repaired tetralogy of Fallot - what does it play and what does it not?
    Int J Cardiol. 2023;385:22.
    >> Share

    July 2023
  310. SISINNI A, Estevez-Loureiro R
    The K-clip: Time for a new tricuspid valve focal annuloplasty system.
    Int J Cardiol. 2023 Jul 31:131234. doi: 10.1016/j.ijcard.2023.131234.
    >> Share

  311. BARKI M, Ielasi A, Buono A, Maffeo D, et al
    Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry.
    Int J Cardiol. 2023 Jul 31:131236. doi: 10.1016/j.ijcard.2023.131236.
    >> Share

  312. SANCHIS L, Farrero M
    Edge to edge mitral valve repair beyond COAPT criteria: A bridge to further therapies for patients with advanced heart failure.
    Int J Cardiol. 2023 Jul 31:131235. doi: 10.1016/j.ijcard.2023.131235.
    >> Share

  313. MIRZAI S, Aleixo GFP, Mazumder S, Berglund F, et al
    Sarcopenia evaluation on cardiac magnetic resonance imaging in older adults for outcomes prediction following surgical aortic valve replacement.
    Int J Cardiol. 2023 Jul 25:131216. doi: 10.1016/j.ijcard.2023.131216.
    >> Share

  314. BHOGAL S, Rogers T, Merdler I, Reddy P, et al
    Evolut PRO/PRO+ versus Evolut R system for transcatheter aortic valve replacement.
    Int J Cardiol. 2023 Jul 19:131196. doi: 10.1016/j.ijcard.2023.131196.
    >> Share

  315. ZHANG X, Jin Q, Pan W, Li W, et al
    First-in-human study of the K-Clip transcatheter annular repair system for severe functional tricuspid regurgitation.
    Int J Cardiol. 2023 Jul 11:131174. doi: 10.1016/j.ijcard.2023.131174.
    >> Share

  316. CHATTERJEE A, Kazui T, Acharya D
    Growing prevalence of aortic stenosis - Question of age or better recognition?
    Int J Cardiol. 2023 Jul 8:131155. doi: 10.1016/j.ijcard.2023.131155.
    >> Share

  317. XU Z, Dai XF, Lin F, Chen LW, et al
    Two-incision totally thoracoscopic mitral valve repair combined with radiofrequency atrial fibrillation ablation in rheumatic mitral valve disease: Early results of a case series of 43 consecutive patients.
    Int J Cardiol. 2023 Jul 8:131158. doi: 10.1016/j.ijcard.2023.131158.
    >> Share

  318. MASSERA D, Sherrid MV, Maron MS, Rowin EJ, et al
    How common is hypertrophic cardiomyopathy... really?: Disease prevalence revisited 27 years after CARDIA.
    Int J Cardiol. 2023;382:64-67.
    >> Share

  319. SA MP, Tasoudis P, Jacquemyn X, Van den Eynde J, et al
    Long-term outcomes of valve-sparing root versus composite valve graft replacement for acute type A aortic dissection: Meta-analysis of reconstructed time-to-event data.
    Int J Cardiol. 2023;382:12-19.
    >> Share

    June 2023
  320. MARGONATO D, Ancona F, Cesari A, Ghantous E, et al
    The long-term clinical course of moderate tricuspid regurgitation.
    Int J Cardiol. 2023 Jun 24:131135. doi: 10.1016/j.ijcard.2023.131135.
    >> Share

  321. LIND A, Esfahan MA, Totzeck M, Al-Rashid F, et al
    Virtual reality-assisted distraction during transcatheter aortic valve implantation under local anaesthesia: A randomised study.
    Int J Cardiol. 2023 Jun 22:131130. doi: 10.1016/j.ijcard.2023.131130.
    >> Share

  322. MUNAFO AR, Scotti A, Estevez-Loureiro R, Adamo M, et al
    2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry.
    Int J Cardiol. 2023 Jun 22:131139. doi: 10.1016/j.ijcard.2023.131139.
    >> Share

  323. LEE M, Shechter A, Han D, Nguyen LC, et al
    Left ventricular morphologic progression in apical hypertrophic cardiomyopathy.
    Int J Cardiol. 2023;381:62-69.
    >> Share

  324. BOURG C, Curtis E, Donal E
    Navigating upstream and downstream: Unleashing the prognostic potential of RVFWLS/PASP ratio in severe tricuspid regurgitation.
    Int J Cardiol. 2023 Jun 12:S0167-5273(23)00881.
    >> Share

  325. RAHIMI M, Kpodonu J
    Myectomy or myomectomy, that is the question.
    Int J Cardiol. 2023;380:28.
    >> Share

  326. SCHEFFERS LE, Kok R, van den Berg LE, van den Hout JMP, et al
    Effects of enzyme replacement therapy on cardiac function in classic infantile Pompe disease.
    Int J Cardiol. 2023;380:65-71.
    >> Share

    May 2023
  327. FERSTL P, Achenbach S, Marwan M, Bittner DO, et al
    Comparison of oral anticoagulation by vitamin-K antagonists and non-vitamin-K antagonists for treatment of leaflet thickening after transcatheter aortic valve implantation (TAVI).
    Int J Cardiol. 2023 May 25:S0167-5273(23)00727.
    >> Share

  328. ZHOU Y, Lin X, Zhu Q, Li H, et al
    Association between trajectories in cardiac damage and clinical outcomes after transcatheter aortic valve replacement.
    Int J Cardiol. 2023 May 11:S0167-5273(23)00707.
    >> Share

  329. FRANCESCO A, Davide M, Gregorio M, Matteo B, et al
    Ratio between right ventricular longitudinal strain and pulmonary arterial systolic pressure: A novel prognostic parameter in patients with severe tricuspid regurgitation.
    Int J Cardiol. 2023 May 4:S0167-5273(23)00647.
    >> Share

  330. EGBE AC, Miranda WR, Anderson JH, Pellikka PA, et al
    Left ventricular adaptation to aortic regurgitation in adults with repaired coarctation of aorta.
    Int J Cardiol. 2023 May 4:S0167-5273(23)00650.
    >> Share

    April 2023
  331. AMBROSY AP, Go AS, Leong TK, Garcia EA, et al
    Temporal trends in the prevalence and severity of aortic stenosis within a contemporary and diverse community-based cohort.
    Int J Cardiol. 2023 Apr 27:S0167-5273(23)00601.
    >> Share

  332. SHOJI S, Kuno T, Malik A, Briasoulis A, et al
    Association between institutional volume of transcatheter mitral valve repair and readmission rates: A report from the National Readmission Database.
    Int J Cardiol. 2023 Apr 19:S0167-5273(23)00588.
    >> Share

  333. FUMAGALLI C, Bonanni F, Beltrami M, Ruggieri R, et al
    Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring.
    Int J Cardiol. 2023 Apr 13:S0167-5273(23)00523.
    >> Share

  334. LEIBOWITZ D, Yoshida Y, Jin Z, Nakanishi K, et al
    Factors associated with the progression of aortic valve calcification in older adults.
    Int J Cardiol. 2023 Apr 6:S0167-5273(23)00470.
    >> Share

  335. ELKOUMY A, Jose J, Gunasekaran S, Kumar A, et al
    Angiographic quantification of aortic regurgitation following myval octacor implantation; independent core lab adjudication.
    Int J Cardiol. 2023 Apr 5:S0167-5273(23)00516.
    >> Share

  336. MERLO M, Folgheraiter A, Sinagra G
    Evolving mortality and clinical scenarios in HCM: Where are we?
    Int J Cardiol. 2023;376:97-99.
    >> Share

    March 2023
  337. MENG H, Zhao X, Wang JD, Wan LY, et al
    Comparison between multimodality imaging approaches for measurement of the tricuspid annulus in severe tricuspid regurgitation.
    Int J Cardiol. 2023 Mar 31:S0167-5273(23)00434.
    >> Share

  338. DE MARZO V, Viglino U, Zecchino S, Matos JG, et al
    Supra-renal aortic atheroma extent and composition predict acute kidney injury after transcatheter aortic valve replacement: A three-dimensional computed tomography study.
    Int J Cardiol. 2023 Mar 29:S0167-5273(23)00464.
    >> Share

  339. MENDEL B, Kohar K, Amirah S, Vidya AP, et al
    The outcomes of fetal aortic valvuloplasty in critical aortic stenosis: A systematic review and meta-analysis.
    Int J Cardiol. 2023 Mar 28:S0167-5273(23)00461.
    >> Share

  340. ESPOSITO G, Montalto C, Crimi G, Grippo R, et al
    Time course of ischemic and bleeding burden in consecutive patients undergoing transcatheter aortic valve replacement (FOCUS-ONE registry).
    Int J Cardiol. 2023 Mar 8:S0167-5273(23)00336.
    >> Share

    February 2023
  341. LEONE PP, Gohar A, Pagnesi M, Mangieri A, et al
    Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison.
    Int J Cardiol. 2023 Feb 28:S0167-5273(23)00270.
    >> Share

  342. MALTES S, Abecasis J, Santos RR, Lopes P, et al
    LGE prevalence and patterns in severe aortic stenosis: When "junctional" means the same.
    Int J Cardiol. 2023 Feb 22:S0167-5273(23)00250.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016